InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Chen Shu-Chih, Director. Officer active across 2 companies, notably Atossa Therapeutics, INC.. Aggregated, 3 filings have been published. Split: 1 buy · 0 sell. History available since 12 May 2026. The latest transaction was filed on 12 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations